Psychological Problems Linked to Chantix
Last Updated on June 26, 2017
Investigation Complete
Attorneys working with ClassAction.org have finished their investigation into this matter.
Check back for any potential updates and take a look at our open investigations here. The information on this page is for reference only.
At A Glance
- This Alert Affects
- Patients who attempted suicide resulting in long-term damage and families of patients who committed suicide while taking Chantix.
- Damages
- Chantix has caused depressed moods and suicide in users.
- Company(ies)
- Pfizer
- Additional Details
- Chantix is a non-nicotine pill used in adults who want to quit smoking.
- Date
- On July 1, 2009, the FDA required the makers of Chantix to place a black box warning on the drug outlining the possible risk of depressed moods and suicidal thoughts.
Sold by Pfizer, Chantix helps smokers ease into quitting by eliminating the side effects of nicotine withdrawal. Approved by the FDA in 2006, Chantix has helped many quit smoking. Unfortunately, because the drug affects the brain, it has also caused some harmful psychological side effects.
Chantix users have experienced depression, anxiety and sudden bouts of abnormal behavior. Some have even attempted or committed suicide. It has also been reported that alcohol use increases these psychological side effects. However, the drug contains no warning about consuming alcohol while taking Chantix.
Since the drug’s approval, the FDA has required Pfizer to print these psychological effects on the warning label. If you or a loved one has been hurt by the side effects of Chantix, you may be able to seek compensation.
Before commenting, please review our comment policy.